Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MIR.Vthis companyMedMira Inc.	CA$0.05	-12.31×	-2.47×	232.06×	-21.25×	-152.2%	-411.7%	-1492.6%	-1881.2%	20.1%	30.3%	-5.6%	-0.47×	-3.42×	-3.33×	0.07×	0.0%	4	-53.91	1	C-
AVCR.VAvricore Health Inc.	CA$0.05	-2.72×	13×	9.49×	-3.94×	-985.8%	44.3%	-256.1%	-348.2%	-477.1%	-351.0%	-17.9%	0×	0.19×	-151.48×	2.11×	0.0%	2	-12.33	1	D+
BUX.CNBioMark Diagnostics Inc.	CA$0.45	-40.43×	180.94×	1,001.91×	-40.29×	-101.2%	-539.4%	-3130.7%	-2470.8%	-446.2%	-163.3%	-1.8%	2.19×	-0.07×	-29.59×	0.99×	0.0%	1	4.74	1	D+
MBX.TOMicrobix Biosystems Inc.	CA$0.29	-16.46×	1.33×	1.98×	73.63×	-10.7%	53.0%	-8.5%	-12.1%	-8.1%	-4.4%	-2.4%	0.24×	-12.48×	-1.66×	8.48×	0.0%	3	1.64	2	C
SONA.CNSona Nanotech Inc.	CA$0.26	-21.45×	-1,796.66×	0×	-25.66×	-102.9%	0.0%	0.0%	0.0%	8381.9%	-1239.4%	-2.8%	-7.94×	-0.07×	-89.24×	0.28×	0.0%	2	-74.3	2	C
Peer median	—	-18.96×	7.16×	5.74×	-14.8×	-102.0%	22.1%	-132.3%	-180.1%	-227.1%	-257.2%	-2.6%	0.12×	-0.07×	-59.42×	1.55×	0.0%	2	-5.35	2	—